Scott Poole Email & Phone Number

Tampa, Florida, US

Watford, Hertfordshire, GB

I provide expertise and insight to external and internal stakeholders on the impact of West Area, ENT division (All states west of the Mississippi River)-specific health policy and managed care guidelines for market access.

Vista, California, US

IDN client bill and direct bill contracts with autoimmune disease diagnostics

Vista, California, US

Autoimmune disease diagnostics that includes client bill contracts and direct contracts with all centers of excellence and IDNs west of the Mississippi

Cranbury, New Jersey, US

Commercial launch of new women’s health drug within all payer channels

Oxford, GB

Minneapolis, MN, US

Boston, Massachusetts, US

-Launched Comprehensive Genomic Profiling (DNA sequencing) diagnostic test In Federal Healthcare Systems, & key, strategic commercial payers-Aligned C-Suite Executives and Medical Directors with Internal genomic experts and facilitate presentations-Led in contract (red-line) negotiations with client and internal resources (billing, legal, medical affairs &.

Consultative selling while executing FSS contract pull-through of a bio-engineered, bi-layered, living cell tissue medical device regional VA/DoD wound care centers specializing in Diabetic Foot Ulcers and Venus Stasis Ulcers.

-Managing large wound care centers through consultative selling in the treatment of Diabetic Foot Ulcers and Venus Status Ulcers.-Providing proper coding to maximize appropriate billing for reimbursement-Preparing tissue for patient treatmentACCOMPLISHMENTS:Proposed and closed 4 new BPAs at Madigan, Travis, Elmendorf and TriplerExceeded sales goals in.

• VISN BPA negotiations-Corporate contact for the NAC (National Acquisition Center for the V.A.)-Training field sales management, field sales, clinical services management, and field clinical managers, on V.A. business.
• Recipient of 1 National Sales Leadership Award and 1 Regional Leadership Award in 2011
• Generated $1.7mm additional revenue 2nd year with >25% growth in 2011 and 2012
• Achieved 126% to plan in 2011 while the national commercial attainment was 86% to plan.

-Started as Idaho/Montana/Western Wyoming Territory Manager in 2009-Broke all territory sales records in new territory the first year-Consulting with diabetes educators and endocrinologists on the management of insulin pump therapy and continuous glucose management systems. Accounts include teaching facilities, adult and children diabetes specialty.

US

• Managed the growth of multiple pharmaceutical products through meeting and engaging in clinical discussions with physicians in the disease states of: psychiatry, neurology, primary care and cardiology.ACCOMPLISHMENTS:
• Lead in increased of market share change within two-month period with 2 of 3 products, in the district
• Facilitated formulary review of BC/BS of ID and ID state Medicaid through KOL relationships

• Grow market share for insulin pump medical device and launch new integrated continuous glucose monitoring system to endocrinologist, diabetes educators, and directly to patients. Start medical benefit coverage process.
• Exceeded 2016 sales goals (112%) and 2007 (122%)
• High Achiever Award FY07 (Top 10% of sales force).
• Executed contract with Union Pacific Railroad insurance for coverage and payment of both insulin pumps, CGM and CGMS-Gold
• Executed non-FSS contract for coverage of insulin pump, GCM, and CGMS-Gold at Boise V.A.

US

Responsible to negotiate equal to favorable formulary status with large regional payers for new cardiovascular drug as well as maintain and renew existing formulary contracts. Launched new fenofibrate, Antara Successfully secured both cardiovascular drugs on 3 of 5 state Medicaid formularies

Tokyo, JP

• Executed BPAs with DoD, VA, and Indian Health medical facilities for the treatment of diabetes.-Developed and lead cross-functional team in all activities that achieved favorable formulary status in State Medicaid.
• Awarded favorable formulary status in all 3 Medicaid states up for review (Texas, Louisiana, and Arkansas)
• Initiated and closed 4 BPAs in all 4 target federal facilities (Wilford Hall/Brooke Army Medical Center, William Beaumont Army Medical Center, and Barksdale Air Force Medical Center
• Achieved #1 rank in 2004

Tokyo, JP

• Responsible for launching type two diabetes drug in the Federal Healthcare Systems in a five-state region.-Developed productive, professional relationships at the C-suite level at the VISN, DoD MTFs and IHS.-Organized.
• Assisted in developing a Federal Sales Training Manual for field sales
• Ranked #2 of 8 for first year as Account Manager
• Selected for the Managed Care Marketing product launch national task force for 2003

•  Launched and promoted two “buy & bill” oncology therapies Manage product portfolio of 7 products Successfully launched several new drug compounds Launched and promoted two “buy & bill” oncology therapies Manage.
• Achieved Gold Tier recognition (#2 ranked regionally and top 5% nationally for 1998).
• Accomplished top 10% of goal attainment regionally all four and one-half years.
• Successfully launched five new drugs while achieving 90th percentile in market share nationally.
• Recognized for #1 of sales force nationally for Hycamtin®, Coreg®, Kytril® and #2 for Famvir®.
• Recognized for training skills, requested by Regional Director to assist training the region’s sales team in a product launches.

Bachelor Of Business Administration (B.B.A.), Marketing

Diploma, Genereal Studies